ASHLEY DANIEL: Open Payments
NPI 1306417548 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,273 in 84 payments from 19 companies in 2025. Trend: 2023 $754 · 2024 $2,179 · 2025 $2,273
Food & beverage: $2,273
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $414 |
| Novo Nordisk Inc | 8 | $375 |
| Merck Sharp & Dohme LLC | 12 | $318 |
| Novartis Pharmaceuticals Corporation | 22 | $283 |
| Abbott Laboratories | 1 | $153 |
| Alnylam Pharmaceuticals Inc. | 6 | $141 |
| ABIOMED | 1 | $110 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Esperion Therapeutics, Inc. | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
Products named: LEQVIO, LOKELMA, WINREVAIR, MITRACLIP, Wegovy, AMVUTTRA, VERQUVO, Ozempic.
Industry payments across TN — which companies pay providers there.
